As part of the Western Australian Government’s commitment to the Health and Medical Life Sciences (HMLS) Industry Strategy, eight Western Australian digital health and medical technology (medtech) startups will be supported to exhibit at AusMedtech 2026 at no cost to the exhibitor (excluding pod fit‑out) through the sponsorship of Startup Alley.This initiative provides eligible WA startups with a valuable opportunity to showcase their products and services to a national and international audience, increasing exposure to industry leaders, clinicians, investors, and government stakeholders.
Tag: Life Sciences
Perth Biodesign 10th Anniversary
The evening will bring together national and international innovators, clinicians, academics and investors who have shaped, and continue to shape, the future of healthcare globally.
Designed as both a celebration and a moment of connection, the Gala Dinner will offer a relaxed and elegant setting to engage with the Biodesign community and our national and international guests.
If you would like to attend the Biodesign Innovation Summit earlier in the day, please note that tickets should be purchased separately.
Biodesign Innovation Summit
Join us for the inaugural Biodesign Innovation Summit, presented as part of Perth Biodesign’s 10th-anniversary celebrations, marking a decade of impact in advancing healthcare innovation.
Bringing together leaders from healthcare, investment, research, government, and the startup ecosystem, the Summit will offer a full day of keynotes, panels, and honest conversations exploring what’s working, what’s next, and what Australia’s role looks like on a global stage.
Designed as a full-day experience, the Summit will create space for meaningful connection throughout. Guests will join from across Australia and internationally for a day of shared learning, thoughtful dialogue, and celebration.
If you are interested in attending the Gala Dinner, please note that tickets are limited and available separately.
Virtual Global Expert Program: Patrice Milos
Sharing real-world experience in supporting pharma/biotech innovators, we will explore:
-
An overview of pharmaceutical drug development timelines.
-
The dramatic inflection of novel sequencing technologies, their development and application to rare disease gene identification.
-
The role of molecular diagnostics, including point-of-care, in identifying causative gene mutations.
-
The emergence of gene therapy and other novel modalities to treat rare diseases.
OMRI Speaker Series: Medical Ethics Expert Professor Nikolajs Zeps
The Office of Medical Research and Innovation (OMRI) is pleased to host the second event in its 2026 OMRI Speaker Series, featuring Professor Nikolajs Zeps.
The OMRI Speaker Series provides a regular forum for thought leadership, discussion and sector‑wide engagement across Western Australia’s health and medical research and innovation ecosystem.
In this session, Professor Zeps will share insights drawn from his extensive experience in clinical research leadership, clinical trials and medical ethics. The conversation will focus on the role of ethical leadership and proportionate, risk‑based review in designing high‑quality research, and how clear, consistent ethics processes and collaboration across health services, research organisations and industry can support timely study start‑up and deliver better outcomes for patients and the community.
Rural Innovations Changing Healthcare (RICH) Forum 2026
Rural Innovations Changing Healthcare (RICH) is an online forum linking rural health service providers, consumers and stakeholders to share experiences and explore innovative, rural models of care which have potential for broader implementation.
The theme for RICH 2026 is Innovation with purpose: Transforming rural health for lasting value and impact. Attendees will:
- learn about local health innovations that are having a significant impact for rural health consumers and adding great value to the rural health system
- be inspired by others and gather ideas to adapt to local contexts
- stretch their thinking about what innovations are possible across the rural health system.
Attendees can join us online for the full day or for individual sessions. The full program is now available.
Innovative Industries of the Future (iiF) 2026
A premier economic event series culminating in a two‑day conference in Bunbury, 27–28 October 2026.
Where investors, industry and government connect on advanced manufacturing, energy, agritech and the circular economy.
Why attend:
- Hear directly from leaders in their field offering knowledge and insights applicable to local industries including your workplace
- Network with like-minded leaders, decision-makers and innovators
- Gain insights into emerging technologies and workforce trends
- Be prepared for the trends shaping the future
- Explore investment opportunities
CSIRO Conversations: Quantum for Every Business
Quantum is moving fast and it’s already creating real opportunities for Australian businesses. This event unpacks what’s real and what’s coming next.
Quantum is at the same stage AI was a decade ago, quietly moving from research labs into real world tools. This event helps industry understand what’s real, what’s hype, and where the near term opportunities lie and who can help. Where today’s computers check one option at a time, quantum can explore many possibilities at once. That makes it powerful for decision making and resource management when it comes to things like routing trucks, detecting minerals, managing patients in a hospital, securing communications or modelling new materials.
Quantum is becoming practical and commercially relevant far sooner than most businesses expect. It’s already emerging in:
- Supply chains: quantum inspired optimisation is helping logistics companies reduce fuel use and manage disruptions.
- Finance: banks are exploring quantum safe encryption to protect transactions.
- Quantum sensing: ultra precise measurements for mining, agriculture, health and defence.
Our expert panellists will translate a complex emerging technology into a grounded, industry relevant discussion on:
- What quantum technologies can do today.
- What’s coming next.
- How Australian businesses can prepare responsibly and competitively.
- How quantum intersects with supply chain resilience, national security, and economic pressures.
Pre-submit your questions to the expert panellists ahead of the webinar
From IP to Investment: What Investors Look for in a Patent Portfolio
The first session in Victorian Medtech Skills and Devices Hub’s 2026 Medtech Skills Online Spotlight Series, this free lunchtime webinar will show you how investors assess your IP and how to position it to support funding.
If you’re developing a medtech idea, securing investment depends on more than the innovation itself. Investors look closely at your patent position to assess risk, ownership, and commercial potential.
This session will show you what matters and how to avoid common IP gaps that can delay or block funding. You’ll learn how investors assess these key areas of your patent portfolio and what to prioritise.
WALSIH presents: BioCina Open Door Session
Go behind the scenes, meet experts, and explore partnership and career pathways at a leading Australian CDMO.
BioCina is a global Contract Development and Manufacturing Organisation (CDMO) with deep expertise in small molecules, biologics (microbial, pDNA, mRNA, LNP modalities) delivering integrated drug substance and drug product manufacturing from two GMP facilities in Australia. The Perth facility specialises in sterile fill-finish, covering drug product formulation, aseptic filling and finish operations across multiple formats. With internationally approved facilities and highly experienced teams, BioCina supports innovators from early development through to commercial supply.
This ‘Open Door Session’ of BioCina’s state-of-the-art 14,000m² Perth facility offers a unique opportunity to engage directly with BioCina’s technical experts and a first‑hand look at sterile drug product filling in action.
Attendees will gain insights into manufacturing workflows, quality systems and what collaboration and workforce pathways with BioCina could look like.